A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

• Tarec Christoffer El-Galaly,
• Verena I. Gaidzik,
• Mihnea-Alexandru Gaman,
• Darko Antic,
• Jessica Okosun,
• Mhairi Copland,
• Veronika Sexl,
• Adele K. Fielding,
• Robin Doeswijk,
• Helen Parker,
• Martin Dreyling,
• Konstanze Döhner,
• António Medina Almeida,
• Elizabeth Macintyre,
• John G. Gribben,
• Kirsten Grønbæk,
• on behalf of the EHA Diversity, Equity, and Inclusion Taskforce

Affiliations

Tarec Christoffer El-Galaly

1 Department of Hematology, Aalborg University Hospital, Aalborg, Denmark

Verena I. Gaidzik

2 Department of Internal Medicine III, University Hospital of Ulm, Germany

Mihnea-Alexandru Gaman

3 Faculty of Medicine “Carol Davila” University of Medicine and Pharmacy Bucharest Romania & Department of Hematology Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania

Darko Antic

4 Clinic for Hematology, University Clinical Center of Serbia and Faculty of Medicine, University of Belgrade, Serbia

Jessica Okosun

5 Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom

Mhairi Copland

6 Paul O’Gorman Leukaemia Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom

Veronika Sexl

7 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria

Adele K. Fielding

8 UCL Cancer Institute, London, United Kingdom

Robin Doeswijk

9 European Hematology Association, EHA Executive Office, The Hague, The Netherlands

Helen Parker

9 European Hematology Association, EHA Executive Office, The Hague, The Netherlands

Martin Dreyling

10 Department of Medicine III, LMU Hospital, Munich, Germany

Konstanze Döhner

2 Department of Internal Medicine III, University Hospital of Ulm, Germany

António Medina Almeida

11 Department of Clinical Hematology, Hospital da Luz, Lisbon, Portugal

Elizabeth Macintyre

13 Université Paris Cité, CNRS, Inserm, INEM, F- 75015 Paris, France

John G. Gribben

15 Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom

Kirsten Grønbæk

16 Department of Hematology, Rigshospitalet, Copenhagen, Denmark

on behalf of the EHA Diversity, Equity, and Inclusion Taskforce